GlassScriptPhysician profile
Jay Naresh Shah
NPI 1497989164
$18,081.58
in general payments reported to CMS, 2019-2025
23 companies · $4,853 in 2025
The $4,853 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,319 · 2020: $2,956 · 2021: $3,012 · 2022: $3,824 · 2023: $698 · 2024: $1,422 · 2025: $4,853.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,357 · Food and Beverage: $2,615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,357.07 |
| Food and Beverage | $2,614.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $10,532.76 | 2020-2025 | |
| Arthrex, INC. | $3,064.53 | 2022-2025 | |
| Smith+Nephew, INC. | $2,400.49 | 2020-2025 | Aetos Shoulder System, Evos, Twinfix |
| Cdc Medical LLC | $1,184.00 | 2019 | |
| Medical Device Business Services, INC. | $162.23 | 2021-2023 | Inhance |
| Total Joint Orthopedics, INC. | $156.33 | 2023 | |
| Medtronic, INC. | $115.19 | 2021 | |
| Zimmer Biomet Holdings, INC. | $69.52 | 2019 | |
| Bioventus LLC | $54.51 | 2020-2023 | Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $52.35 | 2023-2024 | Orthovisc, Monovisc |
| Pacira Therapeutics, INC. | $41.40 | 2019 | |
| Stryker Corporation | $32.92 | 2020 | |
| Innovation Technologies INC | $27.82 | 2025 | Irrisept |
| Tactile Systems Technology INC | $26.25 | 2023 | Entre Plus, Flexitouch Plus |
| Melinta Therapeutics, LLC | $23.86 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $20.74 | 2025 | Euflexxa |
| Ethicon US, LLC | $18.55 | 2024 | Surgicel Nu-Knit, Vistaseal, Surgiflo Hemostatic Matrix |
| Heron Therapeutics, INC. | $17.83 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.42 | 2025 | Iovera, Zilretta |
| Boston Scientific Corporation | $17.15 | 2022 | |
| Abbvie INC. | $16.73 | 2024 | |
| Vericel Corporation | $15.05 | 2020 | |
| Medtronic USA, INC. | $13.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.